Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-33,080
Closed -$963K 60
2022
Q1
$963K Buy
+33,080
New +$776K 0.6% 40
2021
Q1
Sell
-30,450
Closed -$408K 80
2020
Q4
$408K Buy
+30,450
New +$325K 0.22% 77

Other funds holding CCJ

Geneva Partners's CCJ Position: Q2 2022 in Review

Geneva Partners sold out of Cameco (CCJ) in Q2 2022, closing a stake of 33,080 shares — an estimated $963K sold.

Geneva Partners first reported a position in CCJ in Q4 2020 and held it in 2 quarters. The position peaked at $963K in Q1 2022. 415 funds tracked by Wall St. Rank hold CCJ as of Q2 2022.

  • Geneva Partners reported no remaining Cameco position as of Q2 2022 after selling out during the quarter.
  • Geneva Partners sold 33,080 Cameco shares in Q2 2022, an estimated $963K.
  • Geneva Partners first reported a position in Cameco in Q4 2020 and held it in 2 quarters.
  • Geneva Partners's Cameco position peaked at $963K in Q1 2022.
  • 415 funds tracked by Wall St. Rank held Cameco as of Q2 2022.

Based on Geneva Partners's 13F filing for Q2 2022, filed 25 Jul 2022.